Method for Fabricating Nanoparticles
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 61/437,142, filed Jan 28, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,546,521 | Method for Fabricating Nanoparticles In force · High confidence | Cerulean Pharma Inc. | In force | High confidence | ||
| US 8,809,492 | Method For Fabricating Nanoparticles In force · High confidence | Cerulean Pharma Inc. | In force | High confidence | ||
| Application 14/457,835 | Method for Fabricating Nanoparticles Abandoned Abandoned Nov 9, 2015 | Cerulean Pharma Inc. | Abandoned | Abandoned Nov 9, 2015 |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Cerulean Pharma Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.